HEALTH AND BEAUTY CLOSE-UP-15 October 2008-Cordis Bolsters Senior-Level Team(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com

Cordis, a company in transforming cardiovascular care, announced three new senior-level appointments.

Carl J. St. Bernard has been named Vice President,

"Cordis continues to attract top talent both from within Johnson & Johnson and from across the healthcare industry," said Seth Fischer, Worldwide Franchise Chairman, Cordis "I'm confident that these three outstanding leaders will strengthen Cordis and our ability to serve customers in the rapidly changing cardiovascular marketplace."

Carl J. St. Bernard joins Cordis after serving as General Manager of the Magnetic Resonance Imaging (MRI) in the Healthcare Division at General Electric (GE), where he was instrumental in driving revenue, margin, and market share growth.

Paul I. Chang, M.D., who is succeeding Dr. Dennis Donohoe, who retired in August, will become a key member of the research and development leadership team and will be responsible for clinical development strategy, clinical trial execution, and the Program Management Office (PMO). Chang joined Johnson & Johnson Pharmaceutical Research and Development (J&J PRD) in 2006 as Therapeutic Area Head of Cardiovascular and transitioned to head of Internal Medicine, J&J PRD late last year.

As vice president of Health Economics and Reimbursement, Ryan H. Saadi will play a critical role in Cordis' future global growth, especially as the healthcare and medical device industry changes. Saadi joins Cordis from Genzyme where he was vice president, Global Health Outcomes and Strategic Pricing, and supervised U.S. and European-based health economics and outcomes research, pricing and reimbursement teams.

Cordis, a Johnson & Johnson company, is engaged in the development and manufacture of interventional vascular technology.

((Comments on this story may be sent to health@closeupmedia.com))

((Distributed via M2 Communications Ltd - http://www.m2.com))